The digital tools
A suite of digital tools across the care pathway.
The project evaluates four complementary tools that work at different levels of the healthcare system.
What is ENTER?
ENTER (E-DetectioN Tool for Emerging mental disorders) is an online, self-report screening tool designed to support the early identification of young people (12-35 years) in the community who may be experiencing emerging mental health difficulties, including risk states for psychosis and bipolar disorder. The ENTER tool was originally developed and tested in the United Kingdom.
How does it work?
ENTER can be accessed directly by young people themselves and provides a universal, low-threshold, and community-based approach to early detection. Users are invited to complete a brief online assessment combining validated self-report questionnaires and short cognitive tasks, covering psychological symptoms, functioning, and relevant risk indicators. By using a widely accessible digital format, ENTER aims to extend early detection beyond traditional healthcare settings and support timely recognition and referral.
Where is ENTER being evaluated?
Within the ePreventPsych project, ENTER is being developed and evaluated as a scalable early-detection tool across several European countries. Its feasibility, usability, and acceptability are currently being studied in the Netherlands, Italy, and Spain.
This study is open to residents of the Netherlands, Italy, or Spain. ENTER is a research screening tool and does not provide mental health support, diagnosis, or treatment.
Explore country-specific information, eligibility criteria and local contacts:
Read more about ENTER
What is P Risk?
P Risk is a clinical decision-support tool designed to help family doctors (GPs) identify people who are at increased risk of developing psychosis before it begins or is formally diagnosed. It works by analysing routinely collected electronic health record data (such as age, sex, social background, smoking history, mental health consultations, and prescriptions) to calculate an individual’s likelihood of developing psychosis over the next several years.
How does it work?
The tool was first developed and tested using large primary care datasets, showing good accuracy in distinguishing patients who later developed psychosis from those who did not. It has since been externally validated in a separate set of UK primary care records, confirming its strong performance in predicting future psychosis risk and supporting its potential use in general practice.
Ultimately, P Risk aims to support earlier recognition, more timely referrals to specialist care, and improved outcomes for individuals at elevated risk of psychosis.
P Risk within ePreventPsych
Within the ePreventPsych project, P Risk is under evaluation as a scalable early-detection tool across several European countries. Its feasibility, usability, and acceptability are currently being studied in Sweden, the Netherlands, and Spain.
What is the Transdiagnostic Risk Calculator?
The Transdiagnostic Risk Calculator is a clinical tool designed to estimate the likelihood that a person receiving secondary mental health care will develop psychosis or bipolar disorder within six years of their first recorded mental health diagnosis. It is described as “transdiagnostic” because it can be applied across a wide range of non-psychotic mental health conditions, rather than focusing on a single diagnosis or symptom group.
How does it work?
The calculator uses information routinely collected in clinical records, including sociodemographic details, clinical diagnoses, medication use, hospital admissions, and recorded symptoms, substance use, and other clinical indicators, to generate an individualised risk estimate. By drawing on data already available in mental health services, it helps identify people who may be at increased risk but who might not otherwise be flagged for specialist early-intervention assessment.
The Transdiagnostic Risk Calculator is intended to support clinicians in the earlier recognition, closer monitoring, and more informed decision-making for people at elevated risk of developing serious mental illness.
Evaluation within ePreventPsych
Within the ePreventPsych project, the Transdiagnostic Risk Calculator is under evaluation as a scalable early-detection tool across several European countries. Its feasibility, usability, and acceptability are currently being studied in Sweden, Italy, the Netherlands, Spain and Denmark.
Read more about Transdiagnostic Risk Calculator
What is PsyMetRiC?
PsyMetRiC (Psychosis Metabolic Risk Calculator) is a clinical prediction tool designed to help health professionals estimate a young person’s future risk of developing physical health problems, especially metabolic syndrome, which includes conditions like high blood pressure, high blood sugar, abnormal cholesterol levels, and excess abdominal fat, that often occur in people with psychosis. These physical issues are important because they increase the risk of diabetes, heart disease, and other conditions or consequences.
How does it work?
The tool uses commonly available clinical information, such as age, sex, body mass index, smoking status, whether a person is taking certain antipsychotic medications, and blood test results (when available), to calculate the likelihood that someone with a psychotic disorder will develop metabolic syndrome within the next several years.
PsyMetRiC was developed and tested using data from early psychosis services and has been validated both in the UK and in many other international studies, showing that it can provide useful risk estimates in different clinical settings.
This tool aims to support clinicians by offering personalised risk estimates that can inform earlier, more targeted discussions around lifestyle modification, treatment decisions, and preventive healthcare to mitigate future physical health risks.
PsyMetRiC within ePreventPsych
Within the ePreventPsych project, PsyMetRiC is under evaluation as a scalable early-detection tool across several European countries. Its feasibility, usability, and acceptability are currently being studied in Sweden, Spain and Denmark.
